Literature DB >> 23289034

A randomized control trial on the effectiveness of osteopathic manipulative treatment in reducing pain and improving the quality of life in elderly patients affected by osteoporosis.

Liria Papa1, Alfonso Mandara, Michele Bottali, Vincenzo Gulisano, Stefano Orfei.   

Abstract

INTRODUCTION: In the elderly population, a decrease in bone mineral density (osteoporosis) is often associated with a decrease in quality of life and an increase in self reported body pain. This pain originates from the musculoskeletal system and can potentially affect different areas of the body. AIM: The aim of this study was to investigate the effect of osteopathic manipulative treatment (OMT) on self reported pain and quality of life in an elderly population.
DESIGN: Randomized placebo controlled trial.
METHODS: Patients were recruited from the Geriatric Department, Bassini Hospital (Milan, Italy). Patients were randomly assigned to either 6 sessions of OMT (n = 37 patients) or an equivalent number of sham manipulative treatment (SMT) (n = 35 patients). The main outcome variables were QOL measured by QUALEFFO -41 and overall bodily pain measured using a visual analog scale (VAS). Data were analyzed using a two factor ANOVA (treatment × time) for repeated measurements with an α level set at p ≤ 0.05.
RESULTS: Main result of this study was that OMT compared to SMT showed a significant decreased of disability. This effect was demonstrated by a significant interaction in the overall disability score (p =0.001) and the Mental wellbeing (p =0.058), Health perception (p =0.005) and Pain (p =0.003) QUALEFFO -41 subscales, while no significant difference (no interaction) for pain as measured by VAS and for the Daily activities, Walking, Household cleaning and Leisure time activities QUALEFFO -41 subscales (p > 0.05) was found. No adverse effects were recorded during the study. DISCUSSION: This study demonstrated that, in a group of elderly subjects affected by osteoporosis OMT was able to increase self reported QOL while the effect on body pain perception is unclear. This overall improvement in QOL appears to be caused by an improvement in psychological factors (i.e Mental wellbeing and Health perception) rather than physical factors. In fact, all QUALEFFO -41 subscales related to physical function demonstrated no significant interaction. The effect of OMT on Pain perception is less clear. In fact, there was no effect on pain as assessed by VAS while a significant improvement was observed when the QUALEFFO -41 subscale was used. This could be due to the metric properties of the two pain measurement methods; an alternative explanation could be that VAS measures mainly pain quantity while QUA-LEFFO -41 subscales measures mainly pain quality. The lack of effect of OMT on physical function needs to be confirmed by more direct measurements of this variable.

Entities:  

Keywords:  osteopathic treatment; osteoporosis; pain; quality of life

Year:  2012        PMID: 23289034      PMCID: PMC3535995     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  17 in total

1.  Reducing the risk of falls through proprioceptive dynamic posture training in osteoporotic women with kyphotic posturing: a randomized pilot study.

Authors:  Mehrsheed Sinaki; Susan G Lynn
Journal:  Am J Phys Med Rehabil       Date:  2002-04       Impact factor: 2.159

2.  Quality of life and vertebral osteoporosis.

Authors:  J A Kanis; W H Minne; P J Meunier; R Ziegler; E Allender
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

3.  Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

Authors:  P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; U Liberman; H Minne; J Reeve; J Y Reginster; M C de Vernejoul; I Wiklund
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.

Authors:  P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; S Kellingray; A Leplege; U A Liberman; E McCloskey; H Minne; J Reeve; J Y Reginster; M Scholz; C Todd; M C de Vernejoul; I Wiklund
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  Characteristics, satisfaction, and perceptions of patients receiving ambulatory healthcare from osteopathic physicians: a comparative national survey.

Authors:  J C Licciardone; K M Herron
Journal:  J Am Osteopath Assoc       Date:  2001-07

Review 6.  Quality-of-life issues in osteoporosis.

Authors:  Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

7.  Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.

Authors:  A Oleksik; P Lips; A Dawson; M E Minshall; W Shen; C Cooper; J Kanis
Journal:  J Bone Miner Res       Date:  2000-07       Impact factor: 6.741

8.  Patient satisfaction and clinical outcomes associated with osteopathic manipulative treatment.

Authors:  John Licciardone; Russell Gamber; Kathryn Cardarelli
Journal:  J Am Osteopath Assoc       Date:  2002-01

9.  Patient perception of osteopathic manipulative treatment in a hospitalized setting: a survey-based study.

Authors:  Matthew Pomykala; Brian McElhinney; Bryan L Beck; Jane E Carreiro
Journal:  J Am Osteopath Assoc       Date:  2008-11

10.  Quality of life in post-menopausal osteoporosis.

Authors:  Maria Luisa Bianchi; Maria Rosa Orsini; Silvia Saraifoger; Sergio Ortolani; Giovanni Radaelli; Simonetta Betti
Journal:  Health Qual Life Outcomes       Date:  2005-12-01       Impact factor: 3.186

View more
  1 in total

Review 1.  The paradox of sham therapy and placebo effect in osteopathy: A systematic review.

Authors:  Francesco Cerritelli; Marco Verzella; Luca Cicchitti; Giandomenico D'Alessandro; Nicola Vanacore
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.